COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,221 Articles (22,733 medRxiv, 8,488 bioRxiv)

Most recent first Previous |  Page 849: Articles 8481-8490  | Next

ACE2 engagement exposes the fusion peptide to pan-coronavirus neutralizing antibodies
Low, J. S., Jerak, J., Tortorici, M. A., McCallum, M., Pinto, D., Cassotta, A., Foglierini, M., Mele, F., Abdelnabi, R., Weynand, B., Noack, J., Montiel-Ruiz, M., Bianchi, S., Benigni, F., Sprugasci, N., Joshi, A., Bowen, J. E., Walls, A. C., Jarrossay, D., Morone, D., Paparoditis, P., Garzoni, C., Ferrari, P., Ceschi, A., Neyts, J., Purcell, L. A., Snell, G., Corti, D., Lanzavecchia, A., Veesler, D., Sallusto, F.
10.1101/2022.03.30.486377 — Posted: 2022-03-30
Impact of the Russian invasion of Ukraine onthe COVID-19 pandemic dynamics
Nesteruk, I.
10.1101/2022.03.26.22272979 — Posted: 2022-03-30
CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses
Gummuluru, S., Jalloh, S., Olejnik, J., Berrigan, J., Nisa, A., Suder, E. L., Akiyama, H., Lei, M., Tyagi, S., Bushkin, Y., Muhlberger, E.
10.1101/2022.03.29.486190 — Posted: 2022-03-29
Repeated ethanol exposure and withdrawal alters ACE2 expression in discrete brain regions: Implications for SARS-CoV-2 infection
Balasubramanian, N., James, T. D., Pushpavathi, S. G., Marcinkiewcz, C. A.
10.1101/2022.03.29.486282 — Posted: 2022-03-29
Convergent epitope specificities, V gene usage and public clones elicited by primary exposure to SARS-CoV-2 variants
Lima, N. S., Mukhamedova, M., Johnston, T. S., Wagner, D. A., Henry, A. R., Wang, L., Yang, E. S., Zhang, Y., Birungi, K., Black, W. P., O'Dell, S., Schmidt, S. D., Moon, D., Lorang, C. G., Zhao, B., Chen, M., Boswell, K., Roberts-Torres, J., Davis, R. L., Peyton, L., Narpala, S. R., O'Connell, S., Wang, J., Schrager, A., Talana, C. A., Leung, K., Shi, W., Khashab, R., Biber, A., Zilberman, T., Rhein, J., Vetter, S., Ahmed, A., Novik, L., Widge, A., Gordon, I., Guech, M., Teng, I.-T., Phung, E., Ruckwardt, T., Pegu, A., Misasi, J., Doria-Rose, N. A., Gaudinski, M., Koup, R. A., Kwong, P. D., McDermott, A. B., Amit, S., Schacker, T. W., Levy, I., Mascola, J. R., Sullivan, N. J., Schramm, C. A., Douek, D. C.
10.1101/2022.03.28.486152 — Posted: 2022-03-29
Subcellular mapping of the protein landscape of SARS-CoV-2 infected cells for target-centric drug repurposing
Kaimal, J. M., Tampere, M., Le, T. H., Axelsson, U., Xu, H., Axelsson, H., Backstrom, A., Marabita, F., Moussaud-Lamodiere, E., Njenda, D., Sepulveda, C. O., Ouyang, W., Seashore-Ludlow, B., Vernersson, C., Mirazimi, A., Lundberg, E., Ostling, P., Stadler, C.
10.1101/2022.03.29.482838 — Posted: 2022-03-29
Discovery of a druggable copper-signaling pathway that drives cell plasticity and inflammation
Solier, S., Muller, S., Caneque, T., Versini, A., Baron, L., Gestraud, P., Servant, N., Emam, L., Mansart, A., Pantos, G. D., Gandon, V., Sencio, V., Robin, C., Trottein, F., Begue, A.-L., Salmon, H., Durand, S., Wu, T.-D., Manel, N., Puisieux, A., Dawson, M. A., Watson, S., Kroemer, G., Annane, D., Rodriguez, R.
10.1101/2022.03.29.486253 — Posted: 2022-03-29
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants
Zhang, J., Han, Z. B., Liang, Y., Zhang, X. F., Jin, Y. Q., Du, L. F., Shao, S., Wang, H., Hou, J. W., Xu, K., Lei, Z. H., Liu, Z. M., Zhang, J., Hou, Y. N., Liu, N., Shen, F. J., Wu, J. J., Zheng, X., Li, X. Y., Li, X., Huang, W. J., Wu, G. Z., Su, J. G., Li, Q. M.
10.1101/2022.03.29.486173 — Posted: 2022-03-29
Mosaic RBD nanoparticles protect against multiple sarbecovirus challenges in animal models
Cohen, A. A., van Doremalen, N. A., Greaney, A. J., Andersen, H., Sharma, A., Starr, T. N., Keeffe, J. R., Fan, C., Schulz, J. E., Gnanapragasam, P. N. P., Kakutani, L. M., West, A. P., Saturday, G., Lee, Y. E., Gao, H., Jette, C. A., Lewis, M. G., Tan, T. K., Townsend, A. R., Bloom, J. D., Munster, V. J., Bjorkman, P. J.
10.1101/2022.03.25.485875 — Posted: 2022-03-28
Unique molecular signatures sustained in circulating monocytes and regulatory T cells in Convalescent COVID-19 patients
Hoffmann, A. D., Weinberg, S., Swaminathan, S., Chaudhuri, S., Mubarak, H., Schipma, M., Mao, C., Wang, X., El-Shennawy, L., Dashzeveg, N., Wei, J., Mehl, P., Shihadah, L., Wai, C. M., Ostiguin, C., Jia, Y., D'Amico, P., Wang, N., Luo, Y., Demonbreun, A., Ison, M., Liu, H., Fang, D.
10.1101/2022.03.26.485922 — Posted: 2022-03-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).